Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - activated charcoal, quantity: 0.2 g/ml - suspension - excipient ingredients: propylene glycol; glycerol; sucrose; citric acid; purified water; sodium hydroxide - for the treatment of poisoning and drug overdosage by oral ingestion.

Kanada - angol - Health Canada

arkopharma canada inc. - charcoal activated - capsule - 162mg - charcoal activated 162mg - antacids and adsorbents

Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dynapharm (m) sdn bhd - charcoal, activated -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - activated charcoal, quantity: 40 mg/ml - injection, suspension - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - aid to the stereotactic or ultrasonic localising of small lesions of the breast for later surgical excision.

Egyesült Államok - angol - NLM (National Library of Medicine)

merus labs international inc. - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - gemifloxacin 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies. ) acute bacterial exacerbation of chronic bronchitis (abecb) caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . because fluoroquinolones, including factive, have been associated with serious adverse reactions (see warnings ) and for some patients abecb is self-limiting, reserve factive for treatment of abecb in patients who have no alternative treatment options. community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant s

Egyesült Államok - angol - NLM (National Library of Medicine)

vansen pharma inc. - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - gemifloxacin 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies . ) acute bacterial exacerbation of chronic bronchitis caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant streptococcus pneumoniae , includes isolates previously known as prsp (penicillin-resistant streptococcus pneumoniae ), and are strains resistant to two or more of the following antibiotics: penicillin (mic ≥2 μg/ml), 2nd generation cephalosporins (e.g., cefuroxime), macrolides, tetracyclines and trimethoprim/sulfamethoxazole. to reduce the development

Kanada - angol - Health Canada

koegler laboratories inc. - charcoal activated - powder - 4x - charcoal activated 4x - homeopathic products

Kanada - angol - Health Canada

jamp pharma corporation - charcoal activated - suspension - 200mg - charcoal activated 200mg - antiflatulents

Kanada - angol - Health Canada

jamp pharma corporation - charcoal activated - suspension - 200mg - charcoal activated 200mg - antiflatulents

Málta - angol - Medicines Authority

f. trenka chem.-pharmazeutische fabrik ges.m.b.h. goldeggasse 5, 1040 vienna, austria - charcoal, activated - tablet - charcoal, activated 250 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents